Illustration by Moukkaa
Company Information
As of 10/10/2022
Country
U.S.
Headquarters
Parsippany, N.J.
Industry
Pharmaceuticals
CEO
Kristin Peck
Website
Company Type
Public
Ticker
ZTS
Revenues ($M)
$7,776
Profits ($M)
$2,035
Market Value ($M)
$69,420
Employees
12,100
Market value as of Sept. 30, 2022.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$7,776
16.5%
Profits ($M)
$2,037
24.4%
Assets ($M)
$13,900
-
Total Stockholder Equity ($M)
$4,543
-
Profit Ratios
Profit as % of Revenues
26.2%
Profits as % of Assets
14.7%
Profits as % of Stockholder Equity
44.8%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
427
EPS % Change (from 2020)
24.9%
EPS % Change (5 year annual rate)
20.9%
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
48.2%
Total Return to Investors (5 year, annualized)
36.2%
Total Return to Investors (10 year, annualized)
-
Zoetis Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $6,6756.6% | $1,6389.2% | $13,609 | $3,769 |
| 2020 | $6,2607.5% | $1,5005% | $11,545 | $2,708 |
| 2019 | $5,8259.8% | $1,42865.3% | $10,777 | $2,185 |
| 2018 | $5,3078.6% | $8645.2% | $8,586 | $1,770 |
| 2017 | $4,8882.6% | $821142.2% | $7,649 | $1,487 |
SHOW MORE
